ARTICLE | Clinical News
Neridronic acid regulatory update
December 21, 2016 12:41 AM UTC
Grünenthal said FDA granted breakthrough therapy designation to neridronic acid to treat complex regional pain syndrome (CRPS). The aminobisphosphonate is in Phase III testing and has Fast Track and O...